Pfizer Inc logo

Pfizer Inc (PFE)

Market Closed
28 Mar, 20:00
NYSE NYSE
$
25. 21
+0.2
+0.8%
$
147.23B Market Cap
14.55 P/E Ratio
1.68% Div Yield
32,327,300 Volume
1.43 Eps
$ 25.01
Previous Close
Day Range
24.81 25.22
Year Range
24.48 31.54
Earnings results expected in 30 days

Summary

PFE closed yesterday higher at $25.21, an increase of 0.8% from Thursday's close, completing a monthly decrease of -5.76% or $1.54. Over the past 12 months, PFE stock lost -3.3%.
PFE pays dividends to its shareholders, with the most recent payment made on Mar 07, 2025. The next estimated payment will be in In 2 months on Jun 07, 2025 for a total of $0.43.
The last earnings report, released on Feb 04, 2025, exceeded the consensus estimates by 0.14%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Apr 29, 2025.
The stock of the company had never split.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track PFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

PFE Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Pfizer Inc Dividends

Pfizer Inc logo
PFE In 3 weeks
Estimated
Quarterly
$0.43 Per Share
Pfizer Inc logo
PFE 2 months ago
Paid
Quarterly
$0.43 Per Share
Pfizer Inc logo
PFE 4 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 8 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 10 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 25 Jan 2024
Paid
Quarterly
$0.42 Per Share

Pfizer Inc Earnings

29 Apr 2025 (30 Days) Date
-
Cons. EPS
-
EPS
4 Feb 2025 Date
0.49
Cons. EPS
0.63
EPS
28 Jan 2025 Date
0.49
Cons. EPS
-
EPS
29 Oct 2024 Date
0.62
Cons. EPS
1.06
EPS
30 Jul 2024 Date
0.46
Cons. EPS
0.6
EPS
Pfizer Inc logo
PFE In 3 weeks
Estimated
Quarterly
$0.43 Per Share
Pfizer Inc logo
PFE 2 months ago
Paid
Quarterly
$0.43 Per Share
Pfizer Inc logo
PFE 4 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 8 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 10 months ago
Paid
Quarterly
$0.42 Per Share
Pfizer Inc logo
PFE 25 Jan 2024
Paid
Quarterly
$0.42 Per Share
29 Apr 2025 (30 Days) Date
-
Cons. EPS
-
EPS
4 Feb 2025 Date
0.49
Cons. EPS
0.63
EPS
28 Jan 2025 Date
0.49
Cons. EPS
-
EPS
29 Oct 2024 Date
0.62
Cons. EPS
1.06
EPS
30 Jul 2024 Date
0.46
Cons. EPS
0.6
EPS

Pfizer Inc (PFE) FAQ

What is the stock price today?

The current price is $25.21.

On which exchange is it traded?

Pfizer Inc is listed on NYSE.

What is its stock symbol?

The ticker symbol is PFE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 147.23B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 29, 2025.

Has Pfizer Inc ever had a stock split?

No, there has never been a stock split.

Pfizer Inc Profile

Drug Manufacturers - General Industry
Healthcare Sector
Dr. Albert Bourla D.V.M., Ph.D. CEO
NYSE Exchange
US7170811035 ISIN
US Country
88,000 Employees
24 Jan 2025 Last Dividend
- Last Split
13 Aug 2012 IPO Date

Overview

Pfizer Inc. is a global biopharmaceutical company with a rich history dating back to 1849. Based in New York, New York, Pfizer has established itself as a leader in the discovery, development, manufacture, marketing, distribution, and sale of innovative biopharmaceutical products. Serving a wide range of therapeutic areas, Pfizer's portfolio includes medicines and vaccines that address a variety of health concerns, from cardiovascular metabolic conditions and infectious diseases to chronic immune and inflammatory diseases. The company has a significant global footprint, operating across the United States, Europe, and other international markets, catering to wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and more. Through strategic collaboration agreements with entities like Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Merck KGaA, and BioNTech SE, Pfizer continues to lead in the development of medical breakthroughs for unmet medical needs.

Products and Services

  • Eliquis, Nurtec ODT/Vydura, Zavzpret, and Premarin family brands: Targeting cardiovascular metabolic, migraine, and women's health, these products offer innovative treatments in their respective therapeutic areas.
  • Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands: Focused on infectious diseases with unmet medical needs, including vaccines for various age groups and conditions.
  • Comirnaty and Paxlovid brands: At the forefront of COVID-19 prevention and treatment, offering some of the earliest and most effective vaccines and antiviral treatments against the virus. Furthermore, Pfizer is exploring potential future mRNA and antiviral products.
  • Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands: Offering biosimilars and original treatments for chronic immune and inflammatory diseases, showing Pfizer’s commitment to broadening access to critical medication.
  • Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands: Addressing rare and severe conditions such as amyloidosis, hemophilia, endocrine diseases, and sickle cell disease with cutting-edge biopharmaceutical treatments.
  • Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands: Including sterile injectable and anti-infective medicines that play a vital role in treating various infections and conditions.
  • Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands: A comprehensive list of biologics, small molecules, immunotherapies, and biosimilars for treating cancer and other severe diseases, showcasing Pfizer’s extensive contribution to oncology and other advanced therapeutic areas.
  • Contract Manufacturing: In addition to its extensive pharmaceutical product lineup, Pfizer is also involved in the contract manufacturing business, leveraging its vast infrastructure and expertise to produce medicines for other entities.

Contact Information

Address: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192
Phone: 212 733 2323